(6-Chloro-1,2,3,4-tetrahydronaphthalene-1,1-diyl)dimethanol, 98%, 250mg

2-(Aminooxy)ethanol, 95.0%, 1g

[1-(2-Pyridinyl)propyl]amine dihydrochloride, 95.0%, 100mg

5-(Trifluoromethyl)-1-benzothiophene-2-carboxylic acid, 95.0%, 1g

2-(2-Methoxy-6-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-amine dihydrochloride, 95.0%, 5g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide, 97%, 100mg

5,5-Dimethyl-2-thioxoimidazolidin-4-one, 97%, 250mg

Bicyclo[2.2.1]hept-2-ene, 95.0%, 25g

Methyl 5-methyl-3-isoxazole carboxylate, 97.0%, 1g

3-Chloro-4-methyl-2-thiophenecarboxylic acid, 97.0%, 1g

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate, 97.0%, 100g